| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | TRANSENTERIX INC | 7,546,692 | 22,112,000 | 7.31% | ||
| 2 | ENTELLUS MED INC | 3,489,533 | 76,421,000 | 25.25% | ||
| 3 | OPHTHOTECH CORP | 2,053,143 | 95,533,000 | 31.57% | ||
| 4 | OCULAR THERAPEUTIX INC | 2,585,607 | 108,570,000 | 35.87% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000950123-15-006567, filed 2015.05.15).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
